← USPTO Patent Grants

Inhibition of TNF-alpha by fibroblasts and fibroblast exosomes

Grant US12576112B2 Kind: B2 Mar 17, 2026

Assignee

SPINALCYTE LLC

Inventors

Pete O'Heeron, Thomas Ichim

Abstract

Disclosed are means of suppressing production of the inflammatory cytokine TNF-alpha through contact-dependent and contact-independent means by fibroblast populations and products and/or derivatives of fibroblast populations. In one embodiment, fibroblasts are cultured under conditions allowing proliferation of said fibroblasts, wherein said proliferative status of fibroblasts correlates with the ability to directly suppress TNF-alpha production, and/or to release one or more factors capable of suppressing TNF-alpha production. In one embodiment, fibroblasts are used for treatment of inflammatory diseases by their ability to suppress TNF-alpha production. In other embodiments, conditioned media and/or exosomes of said fibroblasts are utilized to treat inflammatory diseases by their ability to suppress TNF-alpha production.

CPC Classifications

C12N 5/0622 C12N 5/0656 C12N 2502/086

Filing Date

2020-12-22

Application No.

17757387

Claims

17